Please login to the form below

licencing

This page shows the latest licencing news and features for those working in and with pharma, biotech and healthcare.

Chiesi's ultra-rare genetic disorder therapy wins European backing

Europe.”. Lamzede, which has been investigated in 33 patients, both adults and children, and the Italian group expects a licencing decision by the European Commission in the second quarter of 2018.

Latest news

Shire licences Parion dry eye drug in $535m deal

Shire has agreed a licencing deal with Parion Sciences for a dry eye disease drug that bolsters its ophthalmic portfolio, a priority area for the Irish group.
LEO Pharma picks up AZ skin disease drugs in $1bn deal

Gains rights to eczema and psoriasis treatments
Biomedical Catalyst funding 'must continue', says BIA

Moreover, another £1bn-plus has subsequently been raised by BMC-funded companies and academics "in the form of additional private finance, grant funding, via licencing or acquisition.".
Gilead's Harvoni gains NICE yes - but won't face funding delay

The commissioning body, which has control of around 40% of the total £105bn annual NHS budget in England, said that if Sovaldi was used by every patient in its licencing remit,
News in brief, March 07, 2007

Teikoku and Dermatrends have not disclosed whether they will enter into a licencing deal, but are optimistic about prospects for positive results from the development of this prototype.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

Akari Therapeutics strengthens board

Grissinger (pictured right) has spent 22 years at Johnson &Johnson, holding positions of vice president and head of worldwide pharmaceutical licencing, as well as vice president and head of worldwide pharmaceutical

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Project Manager, Medical Communications, London: Excellent Salary

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

Senior Medical Writer: Great salary and bebefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Account Manager – Med Comms – London: Salary TBC

Senior Medical Writer: Great salary and benefits

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Editorial Director – Medical Education – Oxford: Negotiable

Project Manager, Medical Communications, Oxford: Excellent Salary

Senior Account Manager / Account Director: Great salary and bebefits

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Medical Writer, e-learning/ training, London: Excellent Salary

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Editor – Medical Education Agency – Bucks: Salary TBC

Medical Writer - (London, Brighton or Copenhagen): Competitive

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Scientific Director: Great salary and bebefits

Subscribe to our email news alerts

PMHub

Add my company

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation: HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...